GoodRx Holdings, Inc. - Class A Common Stock (GDRX)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / Class A Common Stock
Shares outstanding
108M
Number of holders
165
Total 13F shares, excl. options
142M
Shares change
+10.2M
Total reported value, excl. options
$986M
Value change
+$68.4M
Put/Call ratio
0.73
Number of buys
73
Number of sells
-78
Price
$6.94

Significant Holders of GoodRx Holdings, Inc. - Class A Common Stock (GDRX) as of Q3 2024

210 filings reported holding GDRX - GoodRx Holdings, Inc. - Class A Common Stock as of Q3 2024.
GoodRx Holdings, Inc. - Class A Common Stock (GDRX) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 142M shares .
Largest 10 shareholders include Francisco Partners Management, LP (70.1M shares), VANGUARD GROUP INC (7.91M shares), AMERIPRISE FINANCIAL INC (5.08M shares), Rubric Capital Management LP (4.68M shares), MILLENNIUM MANAGEMENT LLC (4.32M shares), AMERICAN CENTURY COMPANIES INC (4.29M shares), T. Rowe Price Investment Management, Inc. (3.81M shares), LAKEWOOD CAPITAL MANAGEMENT, LP (3.72M shares), Silver Lake Group, L.L.C. (3.53M shares), and RENAISSANCE TECHNOLOGIES LLC (2.99M shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.